Ascrinvacumab (PF-03446962) is a highly humanized IgG2 monoclonal antibody against ALK-1. Ascrinvacumab has a Kd value of 7 nM for human ALK1. Ascrinvacumab has an inhibitory effect on TGF-beta and can be used to study hepatocellular carcinoma (HCC).
CAS Nummer:
[1463459-96-2]
Target-Kategorie:
PF-03446962
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten